Search results
Added:
4 years ago
Heart failure with reduced ejection fraction (HFrEF) and AF share several predisposing risk factors and often coexist in the same population.1 Although AF can be a marker of worsening heart failure (HF), it can also be a main driver of disease progression. The presence of AF in patients with HFrEF is associated with an increased risk of stroke, re-hospitalisations and all-cause death.2 Therefore,…
View more
Added:
3 years ago
As the population ages, the incidence of both AF and heart failure (HF) will continue to increase. By the year 2030, there will be an estimated >12 million patients with AF and >8 million patients with HF.1,2 A significant proportion of patients with HF have reduced (<50%) left ventricular ejection fraction (heart failure with reduced ejection fraction, HFrEF) and the coexistance of AF…
View more
Added:
3 years ago
More than a century after its discovery, Chagas disease still is a major health problem in Latin America, with 5.7 million people in 21 countries being affected by it.1 Moreover, about 70 million people are at risk of acquiring the illness.1 Cases of Chagas disease are now found globally; there are more than 400,000 immigrants with this disease living in Europe (mainly in Spain, Italy and France)…
View more
Added:
1 year ago
Added:
2 years ago
Added:
2 years ago
Added:
2 years ago
Added:
1 year ago
Added:
4 years ago
Heart failure (HF) is a global epidemic which affects about 6 million adults in the US. It is projected that by 2030 the total cost of HF will reach US$70 billion. Despite the development of novel drugs and devices, the mortality burden of HF remains high, with one in three patients dying within 1 year of hospitalisation for HF and 40–50% within 5 years of diagnosis.1
Patients with HF are…
View more
Red Flags in Acute Myocarditis
Added:
2 months ago
Article
